|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,893.90 INR | -1.39% |
|
+4.72% | -14.33% |
| 05:46pm | Indian Stocks Fall Amid Tariff Talks With US | MT |
| 03:35pm | Concord Biotech Successfully Completes EU GMP Inspection at Dholka, India Unit | MT |
Sales 2024 by Business Segment
Sales 2024 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Pharmaceutical Products | |||||
Manufacturing and trading in pharmaceutical products | 512.33Cr | 616.4Cr | 712.93Cr | 853.17Cr | 1.02TCr |
Total Assets | 940.72Cr | 1.18TCr | 1.31TCr | 1.51TCr | 1.7TCr |
Interest Expense | -69.82L | -52.32L | -5.48Cr | -4.51Cr | -2.55Cr |
Income Tax Expense | 45Cr | 78Cr | 63Cr | 82Cr | 104.46Cr |
CAPEX | -156.5Cr | -204.42Cr | -155.5Cr | -145.08Cr | -86Cr |
EBT | 213.64Cr | 312.72Cr | 237.52Cr | 322.01Cr | 412.56Cr |
D&A | 21Cr | 27Cr | 50Cr | 54Cr | 54Cr |
Net Income | 169.11Cr | 234.89Cr | 174.93Cr | 240.09Cr | 308.1Cr |
Geographical Revenue Distribution History
| Fiscal Period: March | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
India | 261.56Cr | 252.65Cr | 337.41Cr | 432.13Cr | 534.21Cr |
Total Assets | 395.71Cr | 572.26Cr | 677.38Cr | 773.3Cr | 794.78Cr |
Others | 170.96Cr | 204.5Cr | 244.07Cr | 273.78Cr | 374.75Cr |
Total Assets | 66.52L | 36.57L | - | - | 2.06Cr |
America | 80Cr | 159.25Cr | 131.45Cr | 147.25Cr | 107.98Cr |
- Stock Market
- Equities
- CONCORDBIO Stock
- Financials Concord Biotech Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition